CCL19 and neoplasm: To fight heterogeneous tumor cells, it is considered to be important to make the TME “hot” by recruiting endogenous immune cells; therefore, IL-7 and CCL19 have been combined as secretory co-factors for CAR T cells in a mastocytoma model (32).